Friday, February 29, 2008

FDA Approves Nexium for Use in Children Ages 1-11 Years
The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD). The agency approved Nexium in two forms, a delayed-release capsule and liquid form. Nexium is approved in 10 milligrams (mg) or 20 mg daily for children 1-11 years old compared to 20 mg or 40 mg recommended for pediatric patients 12 to 17 years of age.

FDA Approves New Orphan Drug for Treatment of Rare Inflammatory Syndromes
Arcalyst is first treatment for extremely rare condition called Cryopyrin-Associated Periodic Syndrome or CAPS

Summit Import Corporation Issues an Alert on Uneviscerated Fish
Summit Import Corp. 100 Summit Place, Jersey City, NJ 07305 is recalling all packages of Sum Cheong Lung brand Dried Fish discovered by New York State Dept. of Agriculture and Markets Food Inspectors during a routine inspection and subsequent analysis of the product by Food Laboratory personnel confirming that the fish had not been eviscerated prior to processing.

Wang Globalnet Issues Allergy Alert on Undeclared Eggs, Peanuts and Milk Allergens in Lotte Margaret Brand Korean Cracker (Feb. 14)
Wang Globalnet of 365 Ten Eyck Street, Brooklyn, NY 11206, is recalling 19 gram packages of Lotte Margaret Brand Korean Cracker because they may contain undeclared eggs, peanuts and milk allergens.

Palo Alto Labs Issues a Voluntary Nationwide Recall of Aspire36 and Aspire Lite, two Products Marketed as Dietary Supplements
Palo Alto Labs, 265 SW Port St. Lucie Blvd., Suite 252, Port St. Lucie, FL 34984, announced today that it is conducting a voluntary nationwide recall of the company's supplement products sold under the name Aspire36 and Aspire Lite.

No comments: